Symbol="GLSI"
AssetType="Common Stock"
Name="Greenwich LifesciencesÂ Inc"
Description="Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 / neu-expressing cancers. The company is headquartered in Stafford, Texas."
CIK="1799788"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="118075000"
EBITDA="-8288521"
PERatio="None"
PEGRatio="None"
BookValue="0.909"
DividendPerShare="0"
DividendYield="0"
EPS="-0.59"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.327"
ReturnOnEquityTTM="-0.512"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.59"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="10.95"
EVToRevenue="-"
EVToEBITDA="-20.36"
Beta="3.202"
num_52WeekHigh="21.5"
num_52WeekLow="7.57"
num_50DayMovingAverage="10.79"
num_200DayMovingAverage="12.59"
SharesOutstanding="12848200"
DividendDate="None"
ExDividendDate="None"
symbol="GLSI"
open="8.99"
high="9.36"
low="8.99"
price="9.18"
volume="23118.00"
latest_trading_day="2023-07-11"
previous_close="9.11"
change="0.07"
change_percent="0.7684%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="36928"
Change_recent_avg="-0.07"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="1086"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="683"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
